schizandrin a has been researched along with tacrolimus in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jiang, W; Kong, L; Wang, X | 1 |
Bi, HC; Chen, X; Huang, M; Li, JL; Qin, XL; Wang, CX; Wang, XD; Wang, Y; Xue, XP; Yang, H; Zhong, GP | 1 |
Bu, F; Cai, W; Jiao, Z; Li, L; Lin, HS; Ma, G; Shin, JG; Xiang, X; Zhang, H; Zhuang, X | 1 |
3 other study(ies) available for schizandrin a and tacrolimus
Article | Year |
---|---|
The effect of deoxyschisandrin on blood tacrolimus levels: a case report.
Topics: Adult; Cyclooctanes; Drug Interactions; Humans; Immunosuppressive Agents; Lignans; Liver Transplantation; Living Donors; Male; Polycyclic Compounds; Tacrolimus | 2010 |
In vivo to in vitro effects of six bioactive lignans of Wuzhi tablet (Schisandra sphenanthera extract) on the CYP3A/P-glycoprotein-mediated absorption and metabolism of tacrolimus.
Topics: Absorption; Animals; ATP Binding Cassette Transporter, Subfamily B; Biological Availability; Caco-2 Cells; Cell Line, Tumor; Cyclooctanes; Cytochrome P-450 CYP3A; Dioxoles; Drugs, Chinese Herbal; Humans; Lignans; Male; Microsomes, Liver; Polycyclic Compounds; Rats; Rats, Sprague-Dawley; Tablets; Tacrolimus | 2014 |
Prediction of Drug-Drug Interaction between Tacrolimus and Principal Ingredients of Wuzhi Capsule in Chinese Healthy Volunteers Using Physiologically-Based Pharmacokinetic Modelling.
Topics: Area Under Curve; Biotransformation; China; Computational Biology; Computer Simulation; Cyclooctanes; Cytochrome P-450 CYP3A Inhibitors; Dioxoles; Dose-Response Relationship, Drug; Drug Interactions; Drugs, Chinese Herbal; Expert Systems; Female; Humans; Immunosuppressive Agents; Lignans; Male; Models, Biological; Polycyclic Compounds; Protective Agents; Software; Tacrolimus | 2018 |